Viewing Study NCT04925934


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2026-05-17 @ 1:06 PM
Study NCT ID: NCT04925934
Status: COMPLETED
Last Update Posted: 2024-07-23
First Post: 2021-05-04
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of VIB7734 for the Treatment of Moderate to Severely Active SLE
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lupus Erythematosus, Systemic View
Keywords: